These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Jadhao SJ, Lee CW, Sylte M, Suarez DL. Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695 [Abstract] [Full Text] [Related]
5. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus. Kilany WH, Hassan MK, Safwat M, Mohammed S, Selim A, VonDobschuetz S, Dauphin G, Lubroth J, Jobre Y. Avian Pathol; 2015 Oct 19; 44(5):333-41. PubMed ID: 26023824 [Abstract] [Full Text] [Related]
7. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy. Kim SM, Kim YI, Park SJ, Kim EH, Kwon HI, Si YJ, Lee IW, Song MS, Choi YK. J Virol; 2017 Mar 15; 91(6):. PubMed ID: 28077631 [Abstract] [Full Text] [Related]
8. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge. Bublot M, Pritchard N, Cruz JS, Mickle TR, Selleck P, Swayne DE. Avian Dis; 2007 Mar 15; 51(1 Suppl):498-500. PubMed ID: 17494618 [Abstract] [Full Text] [Related]
9. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Rauw F, Palya V, Gardin Y, Tatar-Kis T, Dorsey KM, Lambrecht B, van den Berg T. Avian Dis; 2012 Dec 15; 56(4 Suppl):913-22. PubMed ID: 23402112 [Abstract] [Full Text] [Related]
11. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt. Kilany W, Dauphin G, Selim A, Tripodi A, Samy M, Sobhy H, VonDobschuetz S, Safwat M, Saad M, Erfan A, Hassan M, Lubroth J, Jobre Y. Avian Pathol; 2014 Dec 15; 43(6):514-23. PubMed ID: 25245772 [Abstract] [Full Text] [Related]
12. Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens. Tarigan S, Indriani R, Durr PA, Ignjatovic J. Avian Pathol; 2015 Dec 15; 44(4):259-68. PubMed ID: 25915110 [Abstract] [Full Text] [Related]
13. Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses. Kapczynski DR, Tumpey TM, Hidajat R, Zsak A, Chrzastek K, Tretyakova I, Pushko P. Vaccine; 2016 Mar 18; 34(13):1575-1581. PubMed ID: 26868083 [Abstract] [Full Text] [Related]
15. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Isoda N, Sakoda Y, Kishida N, Soda K, Sakabe S, Sakamoto R, Imamura T, Sakaguchi M, Sasaki T, Kokumai N, Ohgitani T, Saijo K, Sawata A, Hagiwara J, Lin Z, Kida H. Arch Virol; 2008 Mar 18; 153(9):1685-92. PubMed ID: 18651092 [Abstract] [Full Text] [Related]
16. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus. Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y. Vaccine; 2015 Feb 25; 33(9):1197-205. PubMed ID: 25613723 [Abstract] [Full Text] [Related]
17. Suboptimal protection against H5N1 highly pathogenic avian influenza viruses from Vietnam in ducks vaccinated with commercial poultry vaccines. Cha RM, Smith D, Shepherd E, Davis CT, Donis R, Nguyen T, Nguyen HD, Do HT, Inui K, Suarez DL, Swayne DE, Pantin-Jackwood M. Vaccine; 2013 Oct 09; 31(43):4953-60. PubMed ID: 23994373 [Abstract] [Full Text] [Related]
18. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia. Swayne DE, Suarez DL, Spackman E, Jadhao S, Dauphin G, Kim-Torchetti M, McGrane J, Weaver J, Daniels P, Wong F, Selleck P, Wiyono A, Indriani R, Yupiana Y, Sawitri Siregar E, Prajitno T, Smith D, Fouchier R. J Virol; 2015 Apr 09; 89(7):3746-62. PubMed ID: 25609805 [Abstract] [Full Text] [Related]
19. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1. Abdelwhab EM, Grund C, Aly MM, Beer M, Harder TC, Hafez HM. Vet Microbiol; 2012 Feb 24; 155(1):13-20. PubMed ID: 21920677 [Abstract] [Full Text] [Related]
20. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens. Zeng X, Chen P, Liu L, Deng G, Li Y, Shi J, Kong H, Feng H, Bai J, Li X, Shi W, Tian G, Chen H. Avian Dis; 2016 May 24; 60(1 Suppl):253-5. PubMed ID: 27309064 [Abstract] [Full Text] [Related] Page: [Next] [New Search]